NCT00971945View on ClinicalTrials.gov

Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Breast Cancer
Interventions
DRUG

Paclitaxel

Solution, I.V., 100 mg/m2, Weekly for 6 of 7 weeks, Until disease progression or unacceptable toxicity became apparent

Trial Locations (4)

464-8681

Local Institution, Nagoya

731-0293

Local Institution, Hiroshima

892-0833

Local Institution, Kagoshima

170-8455

Local Institution, Toshima-ku

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY